| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.11▲ | 4.08▲ | 4.09▲ | 4.10▲ | 4.27▼ |
| MA10 | 4.12▲ | 4.09▲ | 4.05▲ | 4.11▲ | 4.46▼ |
| MA20 | 4.07▲ | 4.10▲ | 4.18▲ | 4.30▼ | 4.61▼ |
| MA50 | 4.29▼ | 4.35▼ | 4.32▼ | 4.53▼ | 12.66▼ |
| MA100 | 4.26▼ | 4.31▼ | 4.41▼ | 4.63▼ | 292.84▼ |
| MA200 | 4.44▼ | 4.58▼ | 4.67▼ | 9.79▼ | 384.16▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.027▲ | 0.020▲ | 0.003▲ | -0.002▼ | 2.930▲ |
| RSI | 52.176▲ | 50.751▲ | 49.459▼ | 46.305▼ | 34.479▼ |
| STOCH | 68.310 | 63.833 | 46.429 | 35.739 | 31.727 |
| WILL %R | -3.571▲ | -3.571▲ | -22.857▲ | -59.155 | -75.259▼ |
| CCI | 74.106 | 80.990 | 62.613 | -7.431 | -135.647▼ |
|
Monday, July 27, 2026 05:05 AM
Filing supports potential development of radiopharmaceuticals, T-cell engagers and other immune-based approaches using a versatile platform approach SEATTLE, WA / ACCESS Newswire / July 27, 2026 / ...
|
|
Tuesday, June 16, 2026 02:15 AM
We are initiating coverage of Aptevo Therapeutics Inc. (NASDAQ: APVO) with a valuation of $30.00. Aptevo is a clinical-stage biotechnology company developing multispecific immunotherapies designed to ...
|
|
Wednesday, January 14, 2026 03:09 AM
The average one-year price target for Aptevo Therapeutics (NasdaqCM:APVO) has been revised to $7,711.20 / share. This is an increase of 1,700.00% from the prior estimate of $428.40 dated December 18, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/08/26 | 4.19 | 4.19 | 4.19 | 4.19 | 3,384 |
| 06/08/26 | 4.1086 | 4.1086 | 3.96 | 4.07 | 25,229 |
| 05/08/26 | 4.1135 | 4.19 | 4.01 | 4.19 | 3,461 |
| 04/08/26 | 3.95 | 4.18 | 3.95 | 4.09 | 8,488 |
| 03/08/26 | 4.01 | 4.08 | 3.90 | 3.95 | 11,089 |
| 31/07/26 | 4.07 | 4.11 | 4.07 | 4.11 | 2,453 |
| 30/07/26 | 4.085 | 4.21 | 3.90 | 4.13 | 11,176 |
| 29/07/26 | 4.20 | 4.215 | 3.945 | 3.98 | 22,251 |
| 28/07/26 | 4.21 | 4.3399 | 4.17 | 4.21 | 7,902 |
| 27/07/26 | 4.45 | 4.45 | 4.1684 | 4.21 | 37,978 |
|
|
||||
|
|
||||
|
|